What we checked for Trimi, when, and what we observed — so our figures are traceable.
| Provider | Trimi |
|---|---|
| Source | Trimi published pricing |
| Date checked | July 2026 |
| Pricing observed | Flat-rate ~$125/mo on an annual plan (~$1,500/yr); ~$235 month-to-month; flat across doses; advertised all-inclusive; 503A sterile compounding. |
| Change since last check | First recorded check — no prior snapshot to compare. Future checks will note changes here. |
We record what we observed from publicly available information on the date shown. We do not publish screenshots or store provider pages; figures are summarized in our own words and may change — verify current pricing directly. Compounded tirzepatide is not FDA-approved.
If Trimi's pricing has changed, submit a correction or, if you operate Trimi, a provider update. We verify before changing any page.